ES502429A0 - Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina - Google Patents

Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina

Info

Publication number
ES502429A0
ES502429A0 ES502429A ES502429A ES502429A0 ES 502429 A0 ES502429 A0 ES 502429A0 ES 502429 A ES502429 A ES 502429A ES 502429 A ES502429 A ES 502429A ES 502429 A0 ES502429 A0 ES 502429A0
Authority
ES
Spain
Prior art keywords
dihidroxipropil
chlorobencidril
piperacine
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES502429A
Other languages
English (en)
Other versions
ES8203352A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Selvi and C SpA
Original Assignee
Selvi and C SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Selvi and C SpA filed Critical Selvi and C SpA
Publication of ES8203352A1 publication Critical patent/ES8203352A1/es
Publication of ES502429A0 publication Critical patent/ES502429A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES502429A 1980-05-23 1981-05-22 Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina Granted ES502429A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22283/80A IT1140978B (it) 1980-05-23 1980-05-23 1-(4-clorobenzidril)-4-(2,3-diidros sipropil)-piperazina, metodi per la sua preparazione e relative composizione farmaceutiche

Publications (2)

Publication Number Publication Date
ES8203352A1 ES8203352A1 (es) 1982-04-01
ES502429A0 true ES502429A0 (es) 1982-04-01

Family

ID=11194137

Family Applications (1)

Application Number Title Priority Date Filing Date
ES502429A Granted ES502429A0 (es) 1980-05-23 1981-05-22 Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina

Country Status (8)

Country Link
JP (1) JPS5731678A (es)
BE (1) BE888811A (es)
DE (1) DE3118162C2 (es)
ES (1) ES502429A0 (es)
FR (1) FR2482965A1 (es)
GB (1) GB2076403B (es)
IT (1) IT1140978B (es)
NL (1) NL8102361A (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3611276A1 (de) * 1986-04-04 1987-11-26 Unilever Nv Verpackung mit margarine oder aehnlichem brotaufstrich
JPH01226575A (ja) * 1988-02-25 1989-09-11 Mitsubishi Plastics Ind Ltd もずくの包装体
SE9504661D0 (sv) 1995-12-22 1995-12-22 Astra Pharma Inc New compounds
SE9904673D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE9904674D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0001209D0 (sv) 2000-04-04 2000-04-04 Astrazeneca Canada Inc Novel compounds
ATE420866T1 (de) 2001-05-18 2009-01-15 Astrazeneca Ab 4-(phenylpiperazinylmethyl) benzamidderivate und deren verwendung zur behandlung von schmerzen, angst oder gastrointestinalen störungen
SE0203300D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203302D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
SE0203303D0 (sv) 2002-11-07 2002-11-07 Astrazeneca Ab Novel Compounds
KR101234421B1 (ko) 2004-08-02 2013-02-18 아스트라제네카 아베 디아릴메틸 피페라진 유도체, 이의 제조 방법 및 용도
HU227074B1 (en) * 2005-12-08 2010-06-28 Egis Gyogyszergyar Nyrt An optically active carbamic acid derivative, method for producing the same and use as a pharmaceutical intermediate
US7989623B2 (en) 2007-11-21 2011-08-02 Synthon Bv Process for making n-(diphenylmethyl)piperazines
PL2062881T3 (pl) * 2007-11-21 2011-07-29 Synthon Bv Sposób wytwarzania N-(difenylometylo)piperazyn

Also Published As

Publication number Publication date
DE3118162C2 (de) 1984-07-26
NL8102361A (nl) 1981-12-16
JPS5731678A (en) 1982-02-20
GB2076403B (en) 1983-11-16
GB2076403A (en) 1981-12-02
FR2482965A1 (fr) 1981-11-27
JPS6135189B2 (es) 1986-08-12
FR2482965B1 (es) 1984-11-23
DE3118162A1 (de) 1982-02-18
IT1140978B (it) 1986-10-10
ES8203352A1 (es) 1982-04-01
BE888811A (nl) 1981-08-28
IT8022283A0 (it) 1980-05-23

Similar Documents

Publication Publication Date Title
ES522447A0 (es) Procedimiento para la preparacion de 1,4-diceto-pirrollo-3,4-c-pirroles
ES511835A0 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES507667A0 (es) Procedimiento para la preparacion de 8-arilalcohil-3-fenil-3-nortropanoles .
ES503451A0 (es) Procedimiento para la preparacion de 10-(1,2-propadienil)es-teroides
ES502429A0 (es) Procedimiento para la preparacion de 1-(4-clorobencidril)-4-(2,3-dihidroxipropil)-piperacina
ES527894A0 (es) Procedimiento para la obtencion de compuestos de 2-hidroximetil-3-carbamoil-1,4-dihidropiridina
ES512913A0 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
AR229175A1 (es) Procedimiento para la elaboracion de 2,3-dicloro-5-triclorometilpiridina
AR227335A1 (es) Procedimiento para la preparacion de alfa-(3,4,5-trimetoxibenzoiltio)-propionilglicina
ES515972A0 (es) "procedimiento para la preparacion de nuevas 2-fenil-2-(piridiloxi)-etilaminas sustituidas".
ES504503A0 (es) Procedimiento para la preparacion de 3-bencilsulfonil-1-die-tilcarbamoil-1,2,4-triazol
ES544299A0 (es) Procedimiento para la obtencion de 1-(bis-(4-fluorofenil)- metil)-4-(3-fenil-2-propenil)-hexahidro-1h-1, 4-diacepina
AR227697A1 (es) Procedimiento para la preparacion de 3,4-bis-sustituido 1,2,5,-oxadiazol-2-oxidos
MX158871A (es) Procedimiento para la preparacion de 1,2-dicloroetano
ES500618A0 (es) Procedimiento para la preparacion de 2,3-dicloro-2-trifluo- rometil-1,1,1,3,4,4,5,5,5,-nonafluoropentano
MX7052E (es) Procedimiento para la preparacion de 2-metoxi-4-amino-5-alquilsulfonil-n-(3-beta-8-azabiciclo-(3,2,1)octil)-benzamidas
ES528179A0 (es) Procedimiento para la obtencion de 1-fenil-3-azabiciclo(3,1,0)-hexan-2,4-dionas sustituidas
ES507468A0 (es) Procedimiento para la preparacion de acilureas.
ES502212A0 (es) Procedimiento para la preparacion de n-di-n-propil-2,6-dini-tro-4-trifluorometilanilina
AR231981A1 (es) Procedimiento para la preparacion de 1-(1,3-benzodioxol-5-il)-2-pirrolidinona
AR229174A1 (es) Procedimiento para la preparacion de nuevas 4-(3-trifluormetilfenil)-1,2,3,6-tetrahidropiridinas
AR224196A1 (es) Procedimiento para la elaboracion de 4-amino-6-ter.butil-3-mercapto-1,2,4-triazin-5-ona
ES527677A0 (es) Procedimiento para la obtencion de 1-(2,3-dihidro-1,4-benzodioxin-2s-il)-5-(2,3-dihidro)1,4-benzodioxin-2r-il)-3-azapentan-1r-5s-diol
AR228051A1 (es) Procedimiento para la preparacion de nuevos 2-piperidino-4-amino-6,7-dimetoxiquinazolinas sustituidas
ES526569A0 (es) Procedimiento para la preparacion de alcanolaminoxi-derivados de la 3,4-dihidro-2h-1,4-benzotiazin-3-ona

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603